Edition:
United Kingdom

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

7.88USD
15 Dec 2017
Change (% chg)

$-0.13 (-1.62%)
Prev Close
$8.01
Open
$8.10
Day's High
$8.10
Day's Low
$7.50
Volume
8,783
Avg. Vol
21,012
52-wk High
$21.59
52-wk Low
$7.22

Select another date:

Mon, Nov 13 2017

BRIEF-Gemphire Therapeutics reports qtrly loss of $0.82‍​/shr

* Gemphire Therapeutics Inc qtrly loss per share $0.82‍​ Source: (http://bit.ly/2iaJuNF) Further company coverage:

BRIEF-Gemphire announces plans to advance gemcabene into phase 3 clinical development

* Gemphire announces plans to advance gemcabene into phase 3 clinical development

BRIEF-Gemphire Therapeutics Inc files mixed shelf of up to $175 million - SEC filing ‍​

* Gemphire therapeutics inc files mixed shelf of up to $175 million - SEC filing ‍​ Source text: (http://bit.ly/2vRDX2x) Further company coverage:

BRIEF-Gemphire Therapeutics Inc posts Q2 net loss $0.99/shr

* Gemphire announces second quarter 2017 financial results and provides corporate update

BRIEF-Gemphire announces top-line data from royal-1 phase 2b clinical trial in hypercholesterolemic patients

* Gemphire announces top-line data from royal-1 phase 2b clinical trial in hypercholesterolemic patients

BRIEF-Gemphire enters into $15 mln term loan agreement with Silicon Valley Bank

* Gemphire enters into $15 million term loan agreement with silicon valley bank

Select another date: